Like Biotech Stocks? View our Biotech Stocks Directory Get News Alerts on Biotech Stocks
Biotech Stock Breaking News: IMV (Nasdaq: $IMV) (TSX: $IMV.TO) Updates Rapid Progress on COVID-19 Vaccine Program |
BioNTech Shares Rise as FDA Grants It and Partner Pfizer Fast Track Status for Two Covid-19 Vaccine Candidates |
Altimmune Shares Up 20% Upon Forming Partnership for Intranasal COVID-19 Vaccine |
Frost & Sullivan Reveals Technological Advances Facilitating Research across Preclinical Disease Models |
#DefenseStocks Updates: Patriot One (TSX: $PAT.TO) (OTCQX: $PTOTF) Partners with ecoMine Technologies to advance on-the-spot pathogen screening technology; @Patriot1tech |
Preclinical COVID-19 Vaccine Data 'Encouraging' |
Biotech with Phase 3 Rheumatoid Arthritis and Psoriasis Trials Raises Capital, Now 'Funded Through Catalysts' |
#Security / #Covid19 News: Patriot One (TSX: $PAT.TO) (OTCQX: $PTOTF) Partners with ecoMine Technologies via Canada's Digital Technology Supercluster's Covid19 Program; @Patriot1tech |
Biotech Stock News: Novavax (NASDAQ: NVAX) Expands Executive Leadership and Announces Key Promotions |
'Undervalued' Biopharma Gets Breakthrough Status for Alzheimer's Agitation Drug |
First Trust NYSE Arca Biotech ETF ( NYSEArca: FBT ) The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. The fund is non-diversified.
iShares US Healthcare ( NYSEArca: IYH ) The investment seeks to track the investment results of an index composed of U.S. equities in the healthcare sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Health Care Index (the "underlying index"), which measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.
iShares US Healthcare Providers ( NYSEArca: IHF ) The investment seeks to track the investment results of an index composed of U.S. equities in the healthcare providers sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Select Health Care Providers Index (the "underlying index"), which measures the performance of the healthcare providers sector of the U.S. equity market. The fund is non-diversified.
iShares US Medical Devices ( NYSEArca: IHI ) The investment seeks to track the investment results of an index composed of U.S. equities in the medical devices sector. The fund seeks to track the investment results of the Dow Jones U.S. Select Medical Equipment Index (the "underlying index"), which measures the performance of the medical equipment sector of the U.S. equity market. The underlying index includes medical equipment companies such as manufacturers and distributors of medical devices such as magnetic resonance imaging (MRI) scanners, prosthetics, pacemakers, X-ray machines, and other non-disposable medical devices. The fund is non-diversified.
iShares Nasdaq Biotechnology ( NasdaqGIDS IBB ) The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by the NASDAQ OMX Group, Inc. The fund is non-diversified.
Market Vectors Biotech ETF ( NYSE MKT:BBH ) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
PowerShares Dynamic Biotech & Genome ETF ( NYSEArca: PBE ) The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Biotechnology & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of biotechnology companies and genome companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
Everything You Need to Know About Investing in Healthcare Stocks
March 30, 2020 (Investorideas.com Newswire) Healthcare is one of the most favorable areas for stock investors, mainly because of the roughly $7 trillion that's invested in it across the world - in a single year.
The Rise Of The At-Home Testing Market
January 16, 2020 (Investorideas.com Newswire) Have you heard the term personalized medicine? It's the buzzword in use today thanks to the increase in medical tests being conducted at home.
Why Do You Need Birth Injury Lawyer and How They Can Help You?
October 2, 2019 (Investorideas.com Newswire) Childbirth injury is inexcusable. From the moment a child is conceived to the time the delivery is done, it is the responsibility of the doctors to see that the child is delivered with the utmost care and is healthy.
5 Key Tips For Renting a Boardroom
August 14, 2018 (Investorideas.com Newswire) You've arranged to rent virtual offices in Toronto from time to time.
How to Go About Choosing a Medical Malpractice Lawyer
February 13, 2018 (Investorideas.com Newswire) Medical malpractice affects thousands of individuals around the world. If you think you have been injured, or wrongfully treated by a medical professional, you may be entitled to compensation.
Media Central Corporation Inc. Completes Shares for Debt Transaction |
American Aires Announces Agreement with Answer 365 and to Partner with Four Fulfillment Centers |
EGF Theramed Announces Change of Directors and New CEO |
Rainmaker Worldwide and Pi Eco Announce a Strategic Investment and Global Reseller Agreement |
Cell MedX Corp. Reacquires World Wide Exclusivity Rights for the eBalance(R) Device |
Subscribe to Biotech News RSS